| Financial Year |
March 31 2023 |
| Monetary Funds |
822,608,475.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
699,563,092.55 |
| Advances to Suppliers |
80,488,374.68 |
| Other Receivables |
98,771,848.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,566,882.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,450,253.87 |
| Total Current Assets |
1,797,816,996.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
110,399,193.78 |
| Investment Properties |
20,842,172.22 |
| Fixed Assetes |
50,857,616.78 |
| Under-construction Projects |
18,253,707.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,792,093.00 |
| R&D expenses |
-- |
| Goodwill |
2,353,952.12 |
| Long-Term Deferred and Prepaid Expenses |
7,080,104.95 |
| Deferred Income Tax Assets |
17,535,077.10 |
| Other Non-Current Assets |
320,067.36 |
| Sub-Total of Non-Current Assets |
328,648,165.57 |
| Total Assets |
2,126,465,162.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,647,978.00 |
| Accounts Payable |
284,302,066.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
68,871,829.34 |
| Taxes Payable |
14,233,457.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,569,774.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,083,671.12 |
| Other Current Liabilities |
24,329,531.99 |
| Sub-Total of Current Liabilities |
613,961,655.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,603,776.98 |
| Other Non-Current Liabilities |
1,837,500.00 |
| Sub-Total of Non-Current Liabilities |
17,148,847.31 |
| Total Liabilities |
631,110,502.83 |
| Paid-In Capital(Or Share Stock) |
423,230,000.00 |
| Capital Surplus |
507,159,629.82 |
| Surplus Reserve |
62,675,931.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
471,253,850.27 |
| Minority Stockholder's Interest |
3,579,941.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,491,774,717.76 |
| Owner's Equity（Stockholder's Equity） |
1,495,354,659.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,126,465,162.24 |
